Riskpilot← Back to searchSign inGet full accessSciBase AB
ABActiveOrg 5567773899Landsvägen 39Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200922 employees
Revenue 2024
SEK 23,5M
+27% vs 2023
EBITDA margin
-123.2%
-7% vs 2023
Equity ratio
12.0%
Financial strength
Net profit 2024
SEK -23,1M
+21% vs 2023
| Revenue | SEK 23,5M | +27% |
| EBITDA | SEK -28,9M | -7% |
| Net profit | SEK -23,1M | +21% |
| Total assets | SEK 100,7M | +41% |
| Equity | SEK 12,1M | +0% |
| Employees | 22 | — |
Legal name
SciBase AB
Org number
5567773899
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10 februari 2009
Share capital
SEK 100 000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Henriksson Renaudin, Pia Monica i förening med en av ledamöterna Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva forskning, utveckling, marknadsföring, försäljning, distribution och utbildning med avseende på system för biologiska och medicinska tillämpningar, annan biomedicinsk och medicinsk teknisk utrustning samt därmed förenlig verksamhet.
Address
Landsvägen 39
Phone
+46841062000
Email
info@scibase.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 5 475 | 7 172 | 8 874 | 9 173 | 14 207 | 18 442 | 23 455 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −38 800 | −49 364 | −38 668 | −39 920 | −32 366 | −26 780 | −32 494 | −27 306 | −27 118 | −28 896 |
| Depreciation & amort. | — | — | — | — | — | — | — | — | — | — |
| EBIT | −38 800 | −49 364 | −38 668 | −39 920 | −32 366 | −26 780 | −32 494 | −27 306 | −27 118 | −28 896 |
| Net financials | 299 | −138 | −128 | −270 | 52 | −69 | 1 | 3 354 | −4 790 | 5 779 |
| Profit before tax | −38 501 | −49 502 | −38 796 | −40 177 | −32 286 | −26 814 | −32 493 | −23 952 | −29 438 | −23 117 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −38 501 | −49 502 | −38 796 | −40 177 | −32 286 | −26 814 | −32 493 | −23 952 | −29 438 | −23 117 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 23 616 | 21 546 | 20 388 | 21 347 | 24 729 | 40 963 | 51 970 | 52 845 | 71 205 | 100 715 |
| Equity | 9 802 | 9 910 | 9 374 | 12 100 | 12 100 | 12 100 | 12 100 | 12 100 | 12 100 | 12 100 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 13 814 | 11 636 | 11 015 | 9 247 | 12 629 | 28 863 | 39 870 | 40 745 | 59 105 | 88 615 |
| Total debt | 13 814 | 11 636 | 11 015 | 9 247 | 12 629 | 28 863 | 39 870 | 40 745 | 59 105 | 88 615 |
EBITDA margin
-123.2%
This company
15.8%
Market median
-880% vs market
20152024
Equity ratio
12.0%
This company
38.2%
Market median
-69% vs market
20152024
Return on equity
-191.0%
This company
18.4%
Market median
-1138% vs market
20152024
Net profit margin
-98.6%
This company
8.1%
Market median
-1317% vs market
20152024
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20152024
Debt / equity
7.32×
This company
0.62×
Market median
-1081% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BM Chief Auditor | Chief Auditor | 2022 | — | — |
PM Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
SJ Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Scibase Holding Ab (Publ) | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Scibase Holding Ab (Publ)
SciBase AB Board members of SciBase AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Magnus Lagerberg | Chief Auditor | 0 companies |
| Pia Monica Henriksson Renaudin | Chief Executive Officer | 0 companies |
| Simon James Grant | Chief Executive Officer | 0 companies |
| Diana Jolanda Albertina Ferro | Board of Directors | 0 companies |
| Anna Maria Albertina Eriksrud | Board of Directors | 0 companies |
| Thomas Taapken | Board of Directors | 0 companies |
| Tord Bertil Lendau | Chairman | 0 companies |
| Robert Molander | Board of Directors | 0 companies |
| Jesper Høiland | Chairman | 0 companies |